Phase 1Status unknownAge-related condition
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
Safety and Efficacy Investigation of Patients With Parkinson's Disease by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells
- Sponsor
- Hebei Newtherapy BIo-Pharma technology Co., Ltd. (Industry)
- Enrollment
- 20 planned
- Conditions
- Parkinson's Disease
- Interventions
- mesenchymal stem cells
- Ages
- adults, older adults
- Registry
- NCT03550183
Full record on ClinicalTrials.gov
From the registry
This study is to evaluate the safety and efficacy of Umbilical Cord Derived Mesenchymal Stem Cells transplantation in Parkinson's disease.
Primary outcomes
- Changes of the Unified Parkinson's Disease Rating Scale (UPDRS)
History
Study completion
Primary completion
Last registry update
Registered
Started